Quick Answer
BIOCRYST PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 213.06 million shares for the year ending 2025.
- BIOCRYST PHARMACEUTICALS INC showed an increase of +2.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BIOCRYST PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), BIOCRYST PHARMACEUTICALS INC's Common Stock Shares Outstanding has grown by 373.9%.
- Historical annual values: Fiscal year 2025: 213.06 million shares | Fiscal year 2024: 208.54 million shares | Fiscal year 2023: 205.77 million shares | Fiscal year 2022: 187.91 million shares | Fiscal year 2021: 184.35 million shares | Fiscal year 2020: 176.88 million shares | Fiscal year 2019: 154.08 million shares | Fiscal year 2018: 110.06 million shares | Fiscal year 2017: 98.41 million shares | Fiscal year 2016: 73.78 million shares | Fiscal year 2015: 73.36 million shares | Fiscal year 2014: 71.96 million shares | Fiscal year 2013: 59.09 million shares | Fiscal year 2012: 50.89 million shares | Fiscal year 2011: 45.66 million shares | Fiscal year 2010: 44.96 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: